Immunotherapy for Renal Cell Carcinoma
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Immunology and Immunotherapy".
Deadline for manuscript submissions: closed (15 June 2022) | Viewed by 381
Special Issue Editors
Interests: renal cell carcinoma; immune environment; genomics
Special Issue Information
clinical trials. The aim of this Special Issue is to provide a comprehensive overview of the impact of RCC development and progression by considering their association with key features of RCC, namely microenvironment, drug resistance, metabolism, angiogenesis, metastatic process, and immune response.
Keywords
- renal cell carcinoma
- antiangiogenic agents
- tumor immune microenvironment
- inflamed tumor
- immunotherapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.